Functionally relevant changes occur in HIV-infected individuals' alveolar macrophages prior to the onset of respiratory disease

AIDS

Volumn 11, Issue 6, 1997, Pages 765-772

  Lipman, Marc C I ^a   Johnson, Margaret A ^a   Poulter, Len W ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Bronchoalveolar lavage; Cytokines; HIV; Macrophages; Phenotypes

Indexed keywords

INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

EID: 0030903199     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199706000-00010     Document Type: Article

References (52)

1. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection Nature 1995, 373:117-122.
2. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123 126.
3. Pantaleo G, Glazius C, Fausi AS: The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993, 328:327 335.
4. Bofili M, Gombert W, Borthwick NJ, et al.: Presence of CD3+CD8+Bcl-2 (low) lymphocytes undergoing apoptosis and activated macrophages in lymph nodes of HIV-1+ patients. Am J Pathol 1995, 146:1542 1555.
5. Bray DH, Squire SB, Bagdades I, Mulvena PM, Johnson MA, Poulter LW: Alveolar macrophage populations are distorted in immunocompromised patients with pneumonitis. Eur Respir J 1992, 5:545-552.
6. Spiteri MA, Poulter LW: Characteristics of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 1991, 83:157-162.
7. Knight S, Farrant J, Bryant A, et al.: Non adherent low density cells from human peripheral blood contain dendritic cells and monocytes both with veiled morphology. Immunology 1986, 57:5935-603.
8. Romani N, Lenz A, Glassed H, et al.: Cultured human Langerhans cells reversible lymphoid dendritic cells in phenotype and function. J Invest Dermatol 1989, 93:600 608.
9. Poulter LW, Campbell DA, Munro C, Janossy G: Discrimination of macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol 1986, 24:351-357.
10. Van Haarst JMW, Hoogsteden HC, de Wit HJ, Verhoeven GT, Havenith CEG, Drexhage HA: Dendritic cells and their precursors isolated from human bronchoalveolar lavage: immunocytologic and functional properties. Am J Respir Cell Moll Biol 1994, 11:344-350.
11. Noble B, duBois RM, Poulter LW: The distribution of phenotypically distinct macrophage subsets in the lungs of patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol 1989, 76:41-46.
12. Spileri MA, Clarke SW, Poulter LW: Phenotypic and functional changes in alveolar macrophages contribute to the pathogenesis of pulmonary sarcoidosis, Clin Exp Immunol 1988, 74:359-394.
13. Poulter LW, Power C, Burke C: The relationship between bronchial immunopathology and hyperresponsiveness in asthma. Eur Respir J 1990, 3:792-799.
14. Bray DH, Squire SB, Kawana A, Johnson MA, Poulter LW: Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients. Clin Exp Immunol 1993, 91:13-17.
15. Lipman MCI, Johnson MA, Bray DH, Poulter LW: Changes to alveolar macrophage phenotype in HIV infected individuals with normal CD4 counts and no respiratory disease. Thorax 1995, 50:777-781.
16. Burney PGJ, Chinn S: Developing a new questionnaire for measuring the prevalence and distribution of asthma. Chest 1987, 91:74S-83S.
17. Centers for Disease Control: Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. MMWR 1986, 35:334-339.
18. Rosen MJ, Lou Y, Kvale CA, and the Pulmonary Complications of HIV Infection Study Group: Pulmonary function tests in HIV-infected patients without AIDSx Am J Respir Crit Care Med 1995, 152:738-745.
19. Klech H, Pohl W and the European Society of Pneumology Task Group on Bronchalveolar Lavage: Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Eur Respir J 1989, 2:561-585.
20. Kelly PMA, Bliss E, Morton JA, Burns J, McGee JO'D: Monoclonal antibody EBM11: high cellular specificity for human macrophages. J Clin Pathol 1988, 41:510 515.
21. Hogg N, MacDonald S, Shisarenko M, Beverly PL: Monoclonal antibodies specific for human monocytes, granulocytes and endothelium. Immunology 1984, 53:753 767.
22. Janossy G, Bofill M, Poulter LW, et al.: Separate ontogeny of two macrophage-like cell populations in the human fetus. J Immmunol 1986, 136:4354-4361.
23. Campbell DA, Poulter LW, duBois RM: Immunocompetent cells in bronchoalveolar lavages reflect the cell populations in transbronchial biopsies in pulmonary sarcoidosis. Am Res Respir Dis 1985, 132:1300 1306.
24. Janossy G, Bofill M, Poulter LW Two colour immuno-fluorescence analysis of the lymphoid system with monoclonal antibodies. In Immunocytochemistry Today. Edited by Polak J. Van Noorden S, Bristol: J Wright & Sons: 1986:438-447.
25. Agostini C, Semenzato G: Does analysis of bronchalveolar lavage fluid provide a tool to monitor disease progression or to predict survival in patients with HIV-1 infection? Thorax 1994, 49:848 851.
26. Uphm JW, Strickland DH, Bilyk N, Robinson BWS, Holt PG: Alveolar macrophages from humans and rodents selectively inhibit T-cell proliferation but permit T-cell activation and cytokine secretion. Immunology 1995, 84:142 147.
27. Twigg III HL, Soliman DM: Role of alveolar macrophage-T cell adherence in accessory cell function in human immunodeficiency virus-infected individuals. Am J Respir Cell Mol Biol 1994, 11:138-146.
28. Buhl R, Jaffe HA, Holroyd KJ, et al.: Activation of alveolar macrophages in asymptomatic HIV-infected individuals. J Immunol 1993, 150:1019-1028.
29. Twigg III HL, Lipscomb MF, Yoffe B, Barbaro DJ, Weissler JC: Enhanced accessory cell function by alveolar macrophages from patients infected with the human immunodeficiency virus: potential role for depletion of CD4 cells in the lung. Am J Respir Cell Mol Biol 1989, 1:391-400.
30. Lanza F, Ferrari L, Sighinolfi L, et al.: Reduced expression of macrophage-associated antigens on alveolar mononuclear phagocytes from acquired immunodeficiency syndrome. Int J Clin Lab Res 1993, 23:146-150.
31. Donnet-Hughes A, Schiffrin EJ, Huggett AC: Expression of MHC antigens by intestinal epithelial cells. Effect of transforming growth factor-beta 2. Clin Exp Immunol 1995, 99:240 244.
32. Chelen CJ, Fang Y, Freeman GJ, et al.: Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995, 95:1415 1421.
33. Chang C-H, Furue M, Tamaki K: B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-g or by interleukin-10. Eur J Immunol 1995, 25:394-398.
34. Walters EH, Gardiner PV: Bronchoalveolar lavage as a research tool. Thorax 1991, 46:613 618.
35. Steffen M, Reineckrer HC, Peterson J, et al.: Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 1993, 91:31-36.
36. Twigg III HL, Iwamoto GK, Soliman DM: Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 1992, 149:1462-1469.
37. Israel-Biet D, Cadranel J, Beldjord K, Andrieu J-M, Jeffery A, Even P: Tumor necrosis factor production in HIV-seropositive subjects. Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991, 147:490-494.
38. Millar AB, Miller RF, Foley NM, Meager A, Semple SJG: Production of tumor necrosis factor-a by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease. Am J Respir Cell Mol Biol 1991, 5:144-148.
39. Frentin L, Garbisa S, Zambello R, et al.: Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 1992, 166:731-737.
40. 4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 1993, 104:763-769.
41. Agostini C, Trentin L, Zambello R, et al.: Release of granulocytemacrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1 infected patients. A mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992, 149: 3379 3385.
42. Agostini C, Zambello R, Trenlin L, et al.: Expression of TNF receptors by T cells and membrane TNF-a by alveolar macrophages suggests a role for TNF-a in the regulation of the local immune responses in the lung of HIV-1 infected patients. J Immunol 1995, 154:2928 2938.
43. Genis P, Jett M, Bernton FW, et al.: Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J Exp Med 1992, 176:1703 1718.
44. Kandil O, Fishman JA, Koziel H, Pinkston P, Rose RM, Remold HG: Human immunodeficiency virus type 1 infection of human macrophages modulates the cytokine response to Pneumocystis carinii. Infect Immun 1994, 62:644 650.
45. Assoian RK, Fleurdely BE, Stevenson HC, et al.: Expression and secretion of type b transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987, 84:6020 6024.
46. Yamauchi K, Martinet Y, Basset P, Fells GA, Crystal RG: High levels of transforming growth factor-b are present in epithelial lining fluid of the normal human lower respiratory tract. Am Rev Respir Dis 1988, 137:1360 1363.
47. Wahl SM: Transforming growth factor b: the good, the bad, and the ugly. J Exp Med 1994, 180:1587 1590.
48. Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS: Transforming growth factor h suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J Exp Med 1991, 173:589 597.
49. Lazdins JK, Klimkail I, Woods-Cook K, et al.: In vitro effect of transforming growth factor-b on progression of HIV-1 infection in primary mononuclear phagocytes. J Immunol 1991, 147:1201 1207.
50. Navikas V, Link J, Wahren B, Persson CH, Link H: Increased levels of interferon-gamma, IL-4 and transforming growth factor-beta mRNA expressing blood mononuclear cells in human HIV infection. Clin Exp Immunol 1994, 96:59 63.
51. Kekow J, Wachsman W, McCutchan JA, Cronin M, Carson DA, Lotz M: Transforming growth factor h and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci USA 1990, 87:8321 8325.
52. Nunes I, Shapiro RL, Rifkin DB: Characterisation of latent TGF-b activation by murine peritoneal macrophages. J Immunol 1995, 155:1450 1459.